Pricing Log in Create free account

Arvinas, Inc. (ARVN) vs Prothena Corporation plc (PRTA)

Arvinas, Inc. and Prothena Corporation plc are both Biotechnology companies. Arvinas, Inc. and Prothena Corporation plc are of similar size ($453.2M and $439.6M). Prothena Corporation plc grew revenue faster over the last twelve months: 347.4% against −11.9%. Arvinas, Inc. has the higher net margin (−3.45% vs −45.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Arvinas, Inc. leads on 10 and Prothena Corporation plc on 7.

Valuation

Metric ARVN PRTA Biotechnology median
P/E n/m n/m 11.58
P/S 1.63 8.53 9.61
P/B 0.87 1.67 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA 3.32 n/m 0.72
EV/Sales (0.39) 3.39 9.43
Earnings yield (2.22%) (5.38%) (32.28%)
Free cash flow yield (35.57%) (7.15%) (22.27%)

Profitability

Metric ARVN PRTA Biotechnology median
Gross margin 96.69% 100.00% 68.81%
Operating margin (12.13%) (64.64%) 0.00%
Net margin (3.45%) (45.43%) 0.00%
Free cash flow margin (58.05%) (61.03%) 0.00%
Return on equity (1.76%) (8.50%) (50.30%)
Return on assets (1.31%) (7.53%) (45.47%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARVN PRTA Biotechnology median
Revenue growth (TTM) (11.85%) 347.44% 6.78%
EPS growth (last fiscal year) 58.84% (99.56%) 29.88%
Revenue growth, 5-year CAGR 58.93% 62.56% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARVN PRTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.39 23.95 4.74
Net debt to EBITDA 5.62 1.46 1.01

Dividend

Metric ARVN PRTA Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ARVN PRTA Biotechnology median
Market cap 453.16m 439.55m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack